González Ester, Gutiérrez Eduardo, Morales Enrique, Hernández Eduardo, Andres Amado, Bello Ignacio, Díaz-González Rafael, Leiva Oscar, Praga Manuel
Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Kidney Int. 2005 Jul;68(1):263-70. doi: 10.1111/j.1523-1755.2005.00401.x.
Although some studies have shown that the risk to develop proteinuria and renal insufficiency is increased in patients with a remnant kidney (RK) or unilateral renal agenesis (URA), other patients maintain normal renal function and negative proteinuria, and the reasons to explain these different outcomes are not known.
We performed a retrospective study of 54 patients with a severe reduction in renal mass (33 patients with URA and 21 with RK). Follow-up was 100 +/- 72 months.
Twenty patients (group 1) showed normal renal function at presentation, whereas the 34 remaining (group 2) had proteinuria, and some of them renal insufficiency. Group 2 patients were older and had a higher blood pressure and BMI than group 1 patients. Eleven patients of group 1 remained normal throughout follow-up (group 1A), whereas the remaining 9 developed proteinuria/renal insufficiency (group 1B). BMI at presentation was significantly higher in group 1B: 27 +/- 3.6 kg/m(2) versus 21.6 +/- 2.6 kg/m(2), and BMI was the only factor statistically associated with the risk to develop proteinuria/renal insufficiency in group 1. Among group 2 patients, renal function remained stable in 20 (group 2A), and deteriorated (>50% increase of baseline serum creatinine) in the remaining 14 patients (group 2B). BMI at presentation and treatment with ACEI during follow-up were the only factors statistically associated with the risk for renal failure progression among group 2 patients.
Overweight plays a fundamental role in the appearance of proteinuria and renal damage in patients with severe renal mass reduction.
尽管一些研究表明,残余肾(RK)或单侧肾缺如(URA)患者发生蛋白尿和肾功能不全的风险增加,但其他患者肾功能正常且蛋白尿阴性,而解释这些不同结果的原因尚不清楚。
我们对54例肾实质严重减少的患者进行了一项回顾性研究(33例URA患者和21例RK患者)。随访时间为100±72个月。
20例患者(第1组)就诊时肾功能正常,而其余34例(第2组)有蛋白尿,其中一些患者有肾功能不全。第2组患者比第1组患者年龄更大,血压和体重指数更高。第1组中的11例患者在整个随访过程中保持正常(第1A组),而其余9例出现蛋白尿/肾功能不全(第1B组)。第1B组就诊时的体重指数显著更高:27±3.6kg/m² 对比21.6±2.6kg/m²,体重指数是第1组中与发生蛋白尿/肾功能不全风险唯一有统计学关联的因素。在第2组患者中,20例患者(第2A组)肾功能保持稳定,其余14例患者(第2B组)肾功能恶化(基线血清肌酐增加>50%)。就诊时的体重指数和随访期间使用ACEI治疗是第2组患者中与肾衰竭进展风险唯一有统计学关联的因素。
超重在严重肾实质减少患者蛋白尿和肾损害的出现中起重要作用。